首页> 外文期刊>Journal of endovascular therapy: an official journal of the International Society of Endovascular Specialists >Experience with endovascular abdominal aortic aneurysm repair in nonagenarians.
【24h】

Experience with endovascular abdominal aortic aneurysm repair in nonagenarians.

机译:非agenarians进行血管内腹主动脉瘤修复的经验。

获取原文
获取原文并翻译 | 示例
       

摘要

PURPOSE: To report a single-institution experience with endovascular abdominal aortic aneurysm (AAA) repair (EVAR) in nonagenarians. METHODS: A retrospective review was performed of all patients >90 years old undergoing EVAR over an 8-year period at a major academic medical center. The patient population was investigated for the presence of various comorbidities, initial aneurysm size, successful aneurysm exclusion, perioperative complications, disposition, endoleaks, secondary interventions, and overall survival. RESULTS: EVAR was performed in 18 male nonagenarians (mean age 92.4 years, range 90- 95). Mean aneurysm diameter was 7.3 cm (range 5.5-9.8). The cohort had an average of 3.2 comorbid conditions. Sixteen patients were treated electively, while 2 patients underwent emergent repair for contained rupture and bleeding aortoenteric fistula, respectively. Immediate technical success was 100%. Perioperative local/vascular complications occurred in 4 (22%) patients. Perioperative systemic complications occurred in 3 (17%) patients. There were 2 (11%) perioperative (<30 days) deaths. Three (17%) patients required secondary interventions. Mean survival in patients who expired during the follow-up period beyond the first 30 days was 34 months (range 8-78). Mean survival in 8 patients who are still alive is 17.4 months (range 9-39). CONCLUSION: Endovascular AAA repair in nonagenarians is associated with a high rate of technical success and relatively low morbidity rate. Survival times following successful hospital discharge are significant. Suitable patients over 90 years of age may benefit from an endovascular AAA repair.
机译:目的:报告非老年患者的单机构接受血管内腹主动脉瘤(AAA)修复(EVAR)的经验。方法:回顾性审查了在主要学术医学中心接受了EVAR超过8年的所有90岁以上的患者。对患者人群的各种合并症,初始动脉瘤大小,成功的动脉瘤排除,围手术期并发症,处置,内漏,二次干预和总生存率进行了调查。结果:EVAR是在18位男性非老年人群中进行的(平均年龄92.4岁,范围90-95)。平均动脉瘤直径为7.3 cm(范围5.5-9.8)。该队列平均患有3.2种合并症。择期治疗16例患者,其中2例因主动脉瘘破裂和出血而接受紧急修复。立即的技术成功是100%。 4名(22%)患者发生围手术期局部/血管并发症。 3例(17%)患者发生围手术期全身并发症。围手术期(<30天)死亡2例(11%)。三名(17%)患者需要二次干预。随访期超过前30天的患者的平均生存期为34个月(范围8-78)。 8名仍活着的患者的平均生存时间为17.4个月(范围9-39)。结论:非老年患者的血管内AAA修复与技术成功率高和发病率相对低有关。成功出院后的存活时间很长。 90岁以上的合适患者可从血管内AAA修复中受益。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号